Organization
Array BioPharma Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Array BioPharma Inc.
... quarter and US$ 11 million in the second quarter of 2018 to Array BioPharma for full exclusive global rights of varlitinib were recorded as intangible ...
... BOULDER - Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that Carrie S. Cox has been named Chairman ...
... first quarter and US$11 million in the second quarter of 2018 to Array BioPharma for full exclusive global rights of varlitinib were recorded as intangible ...
... both aggressive and indolent subtypes of relapsed and refractory (R/R) DLBCL. Selumetinib, Array BioPharma and AstraZeneca Selumetinib is an adenosine triphosphate (ATP) independent inhibitor of ...
... BOULDER - Array BioPharma Inc. (NASDAQ: ARRY) today announced that the Committee for Medicinal Products for ...
... Array BioPharma Inc. (NASDAQ: ARRY) today announced that the Committee for Medicinal Products for Human ...
Subscribe now for full coverage on Array BioPharma Inc.
Start My Free Trial